References
- Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530–3.
- Friedman WF, Hirscuklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 1976; 295: 526–9.
- Halliday HL, Hirata T, Brady JP. Indomethacin therapy for large patent ductus arteriosus in the very low birth weight infant: results and complications. Pediatrics 1979; 64: 154–9.
- Cooke RWI, Pickering D. Poor response to oral indomethacin therapy for persistent ductus arteriosus in very low birth weight infants. Br Heart J 1979; 41: 301–3.
- Hallam HI, Kaltwinkel J, Park TS, Krovetz LJ. Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams. Br Heart J 1979; 41: 304–7.
- Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus—a double-blind controlled study. J Pediatr 1981; 98: 137–45.
- Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983; 102: 895–905.
- Walters M. Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus. Br Med J 1988; 297: 773–4.
- Scholz TD, McGuiness GA. Localized intestinal perforation following intravenous indomethacin for patent ductus arteriosus. J Pediatr Gastroenterol Nutr 1988; 7: 773–5.
- Reynolds JEF, Prasad AB, eds. Martindale The Extra Pharmacopoeia, 28th edn. 1982; 257–61.
- Rudd P, Montanez P, Halklidie-Smith K, Silverman M. Indomethacin treatment for patent ductus arteriosus in very low birth weight infants: double blind trial. Arch Dis Child 1983; 58: 267–70.
- Lewis IG, Harvey DP, Maxwell GM. Indomethacin therapy of patent ductus in preterm infants controlled by plasma level. Aust Paediatr J 1985; 21: 181–3.
- Nagaraj HS, Sandhu AS, Cook LN, Buchino JJ, Groff DB. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants. J Pediatr Surg 1981; 16: 1003–7.
- Alpan G, Eyal F, Vinograd I, et al. Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr 1985; 106: 277–81.
- Hervas JA, Masip MC, Alomar A, Bregante JI. Localized intestinal perforation after intravenous indomethacin in a premature infant. Helv Paediatr Acta 1986; 41: 437–40.
- Scholz TD, McGuinness GA. Localized intestinal perforation following intravenous indomethacin for patent ductus arteriosus. J Pediatr Gastroenterol Nutr 1988; 5: 773–5.
- Wolf WM, Snover DC, Leonard AS. Localized intestinal perforation following intravenous indomethacin in premature infants. J Pediatr Surg 1989; 24: 409–10.
- Mellander M, Leheup B, Lindstrom DP, et al. Recurrence of symptomatic patent ductus arteriosus in extremely premature infants treated with indomethacin. J Pediatr 1984; 105: 138–43.